Affordable Sitagliptin combinations for diabetics to be sold at Janaushadhi Kendras
Sitagliptin is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus
Sitagliptin is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus
The findings support the fact that further extension of nationwide cardiovascular disease (CVD) risk identification programs and prevention strategies to reduce the occurrence of cardiovascular diseases are warranted
Confirmed positive phase 3 topline results in addition to Enavogliflozin monotherapy and Metformin combination therapy
This advanced technology for Diabetic Foot Ulcer (DFU), management has a high scope of preventing amputations in diabetic patients. It has no definitive treatment in India. This technology will be available at affordable rates
The aim is to create an awareness programme that will drive diabetic patients to get their eyes tested regularly
A total of 12 generic medicines have been included in the list
Remote screening of diabetic retinopathy can help in early detection, even before there are any noticeable vision changes
Secures high-stakes glaucoma drug in up to $2.45b bet on eye care pipeline
Market grows 12.1%; volume contribution improves as 9 out of 10 key therapies post double-digit growth
Funding will support the expansion of Remidio’s Oculomics platform to identify early signs of pre-eclampsia, anemia and gestational diabetes through retinal imaging, targeting underserved communities
Subscribe To Our Newsletter & Stay Updated